EUVIMEDEUVIMED entdecken
Crossref

Fecal miRNA profiles in colorectal cancers with mucinous morphology

Alessio Naccarati iD, Mihnea P Dragomir iD, Sonia Tarallo iD, Amedeo Gagliardi iD, Virginia Alberini iD, Tomas Buchler iD, Vaclav Liska iD, Gaetano Gallo iD, Veronika Vymetalkova iD, Ludmila Vodickova iD, Pavel Vodicka iD, Barbara Pardini iD und 1 weitere

Mutagenesis · 2025

DOI: 10.1093/mutage/geae015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mutagenesis, 2025. Verfasst von Alessio Naccarati und 12 weiteren Autor:innen. Beteiligte Einrichtung: Genetic and Molecular Epidemiology Unit, Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo 10060, Turin, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs, Feces, Adenocarcinoma, Mucinous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Italian Institute for Genomic Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnostic performance of molecular markers in surrogate tissues like stool may be affected by colorectal cancer (CRC) morphological heterogeneity. The mucinous histotype represents a subgroup of CRC with a peculiar molecular program and unfavorable disease progression. However, the percentage of mucinous morphology necessary to define this subtype is still a matter of debate. In this study, we investigated whether stool miRNA profiles of CRC patients differ in patients with mucinous histopathological subtypes compared to non-mucinous cancers. In this respect, we also explored how the stool miRNA signature reported in our previous multicentric study behaves in this histotype. Small-RNA sequencing was performed in fecal and tissue samples of an Italian cohort (n = 172), including 27 CRC with mucinous morphology (mucinous cancers with ≥ 50% mucinous morphology and those with mucinous component ≥ 5% but < 50%), 58 non-mucinous CRC, and 87 colonoscopy-negative controls. Results were compared with fecal miRNA profiles of a cohort from the Czech Republic (n = 98). Most of the differentially expressed (DE) stool miRNAs (n = 324) were in common between CRC with mucinous morphology and non-mucinous histopathological subtypes in comparison with healthy controls. Interestingly, the altered levels of 25 fecal miRNAs previously identified distinguishing CRC cases from controls in both cohorts were also confirmed after stratification for mucinous morphology. Forty-nine miRNAs were DE exclusively in CRC with mucinous morphology and 61 in non-mucinous CRC. Mucinous cancers and those with mucinous component showed fairly similar profiles that were comparable in the Czech cohort. Among the stool DE miRNAs observed in CRC with mucinous morphology, 20 were also altered in the comparison between tumor and adjacent mucosa tissue. This study highlights miRNAs specifically altered in CRC with mucinous morphology. Nevertheless, the performance of our stool miRNA signature in accurately distinguishing CRC cases from controls was not significantly affected by this histological subtype. This aspect further supports the use of stool miRNAs for noninvasive diagnosis and screening strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMicroRNAsFecesAdenocarcinoma, MucinousHumansMaleFemaleAgedMiddle AgedBiomarkers, TumorGene Expression Regulation, NeoplasticGene Expression Profiling

Stichwörter der Autor:innen

colorectal cancermucinous morphologystool miRNA signaturestumor heterogeneity

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Genetic and Molecular Epidemiology Unit, Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo 10060, Turin, Italy.
  • Candiolo Cancer Institute, FPO IRCCS, Candiolo 10060, Turin, Italy.
  • Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin 10117, Germany.
  • German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Berlin Institute of Health at Charit´e - Universit¨atsmedizin Berlin, Charit´eplatz 1, 10117 Berlin, Germany.
  • Department of Clinical and Biological Sciences, University of Torino, Turin 10100, Italy.

ORCID-Profile: Alessio Naccarati, Mihnea P Dragomir, Sonia Tarallo, Amedeo Gagliardi, Virginia Alberini, Tomas Buchler, Vaclav Liska, Gaetano Gallo, Veronika Vymetalkova, Ludmila Vodickova, Pavel Vodicka, Barbara Pardini, Giulio Ferrero

Förderung

  • Italian Institute for Genomic Medicine

Zitieren

APA

Naccarati, A., Dragomir, M. P., Tarallo, S., Gagliardi, A., Alberini, V., Buchler, T., Liska, V., Gallo, G., Vymetalkova, V., Vodickova, L., Vodicka, P., Pardini, B., & Ferrero, G. (2025). Fecal miRNA profiles in colorectal cancers with mucinous morphology. Mutagenesis. https://doi.org/10.1093/mutage/geae015

Vancouver

Naccarati A, Dragomir MP, Tarallo S, Gagliardi A, Alberini V, Buchler T, et al. Fecal miRNA profiles in colorectal cancers with mucinous morphology. Mutagenesis. 2025. doi:10.1093/mutage/geae015

BibTeX
@article{Naccarati2025,
  author = {Naccarati, Alessio and Dragomir, Mihnea P and Tarallo, Sonia and Gagliardi, Amedeo and Alberini, Virginia and Buchler, Tomas and Liska, Vaclav and Gallo, Gaetano and Vymetalkova, Veronika and Vodickova, Ludmila and Vodicka, Pavel and Pardini, Barbara and Ferrero, Giulio},
  title = {Fecal miRNA profiles in colorectal cancers with mucinous morphology},
  journal = {Mutagenesis},
  year = {2025},
  doi = {10.1093/mutage/geae015}
}
Kostenlos starten →